Leveraging metabolic modeling to identify functional metabolic alterations associated with COVID-19 disease severity.
Leveraging metabolic modeling to identify functional metabolic alterations associated with COVID-19 disease severity.
复制标题
利用代谢建模来识别与COVID-19疾病严重程度相关的功能性代谢改变。
DOI:
10.1007/s11306-022-01904-9
复制
发表时间:
2022-07-11
期刊:
影响因子:
3.6
通讯作者:
Papin, J. A.
中科院分区:
文献类型:
--
作者:
Dillard, L. R.;Wase, N.;Ramakrishnan, G.;Park, J. J.;Sherman, N. E.;Carpenter, R.;Young, M.;Donlan, A. N.;Petri, W.;Papin, J. A.
Since the COVID-19 pandemic began in early 2020, SARS-CoV2 has claimed more than six million lives world-wide, with over 510 million cases to date. To reduce healthcare burden, we must investigate how to prevent non-acute disease from progressing to severe infection requiring hospitalization. To achieve this goal, we investigated metabolic signatures of both non-acute (out-patient) and severe (requiring hospitalization) COVID-19 samples by profiling the associated plasma metabolomes of 84 COVID-19 positive University of Virginia hospital patients. We utilized supervised and unsupervised machine learning and metabolic modeling approaches to identify key metabolic drivers that are predictive of COVID-19 disease severity. Using metabolic pathway enrichment analysis, we explored potential metabolic mechanisms that link these markers to disease progression. Enriched metabolites associated with tryptophan in non-acute COVID-19 samples suggest mitigated innate immune system inflammatory response and immunopathology related lung damage prevention. Increased prevalence of histidine- and ketone-related metabolism in severe COVID-19 samples offers potential mechanistic insight to musculoskeletal degeneration-induced muscular weakness and host metabolism that has been hijacked by SARS-CoV2 infection to increase viral replication and invasion. Our findings highlight the metabolic transition from an innate immune response coupled with inflammatory pathway inhibition in non-acute infection to rampant inflammation and associated metabolic systemic dysfunction in severe COVID-19.
登录
查看更多内容
影响因子:
4.4
作者:
Delattre H;Sasidharan K;Soyer OS
通讯作者:
Soyer OS
影响因子:
8
作者:
Donlan AN;Sutherland TE;Marie C;Preissner S;Bradley BT;Carpenter RM;Sturek JM;Ma JZ;Moreau GB;Donowitz JR;Buck GA;Serrano MG;Burgess SL;Abhyankar MM;Mura C;Bourne PE;Preissner R;Young MK;Lyons GR;Loomba JJ;Ratcliffe SJ;Poulter MD;Mathers AJ;Day AJ;Mann BJ;Allen JE;Petri WA Jr
通讯作者:
Petri WA Jr
影响因子:
4.4
作者:
Kimhofer, Torben;Lodge, Samantha;Nicholson, Jeremy K.
通讯作者:
Nicholson, Jeremy K.
影响因子:
8.4
作者:
Amzat, Jimoh;Aminu, Kafayat;Danjibo, Maryann C.
通讯作者:
Danjibo, Maryann C.
DOI:
10.1126/science.aat3987
发表时间:
2020-05-01
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Knudsen NH;Stanya KJ;Hyde AL;Chalom MM;Alexander RK;Liou YH;Starost KA;Gangl MR;Jacobi D;Liu S;Sopariwala DH;Fonseca-Pereira D;Li J;Hu FB;Garrett WS;Narkar VA;Ortlund EA;Kim JH;Paton CM;Cooper JA;Lee CH
通讯作者:
Lee CH